Screener
Dyne Therapeutics, Inc. DYN Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215702
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Prepaid expenses and other current assets | 48,871 | 16,025 |
| Total current assets | 1,021,027 | 1,126,587 |
| Property and equipment, net | 23,682 | 24,029 |
| Right-of-use assets | 19,652 | 20,742 |
| Restricted cash and other assets | 15,589 | 15,600 |
| Total assets | $1,079,950 | $1,186,958 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Dyne Therapeutics, Inc.'s operating lease ROU assets?
- Dyne Therapeutics, Inc. (DYN) reported operating lease ROU assets of $19.65M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
- Dyne Therapeutics, Inc.'s operating lease ROU assets decreased by 17.7% year-over-year, from $23.88M to $19.65M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s operating lease ROU assets?
- Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s operating lease ROU assets has grown at a 96.9% compound annual growth rate (CAGR), from $700K to $20.74M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Dyne Therapeutics, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude